Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Regen BioPharma Inc | rgbp102016form8k.htm |
October 20, 2016
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Dear Sir/Madam:
We have read the statements included under Item 4.01 in the Form 8-K dated October 19, 2016 of Regen Biopharma, Inc. (the "Company") to be filed with the Securities and Exchange Commission regarding the change of auditors. We agree with such statements insofar as they relate to our firm.
Very truly yours,
/s/ Seale and Beers, CPAs
Seale and Beers, CPAs
Las Vegas, Nevada